Chenxue Qi

Efficiently targeted therapy of glioblastoma xenograft via multifunctional biomimetic nanodrugs

Yafeng Wu, Songqin Liu, Fan Zhang, 2022, Biomaterials Research.

Identification and validation of a novel necroptosis-related molecular signature to evaluate prognosis and immune features in breast cancer

Guoren Zhou, Haojun Xu, Zhipeng Yao, 2023, Apoptosis.

SECTM1 promotes the development of glioblastoma and mesenchymal transition by regulating the TGFβ1/Smad signaling pathway

Guoren Zhou, Xiaochun Jiang, Min Mao, 2024, International journal of biological sciences.

Hollow Cu2MoS4 nanoparticles loaded with immune checkpoint inhibitors reshape the tumor microenvironment to enhance immunotherapy for pancreatic cancer.

Chengyun Yao, Zhipeng Yao, Cheng Wang, 2023, Acta biomaterialia.

SVIL promotes ovarian cancer progression and epithelial-mesenchymal transition under hypoxic conditions through the TGF-β/Smad pathway.

Mengmeng Lyu, Zhipeng Yao, Hongping Xia, 2024, Gynecologic oncology.